Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Brain Communications|March 2, 2023
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension studyDarin T Okuda, Daniel Kantor, Mark Jaros, et al.Brain Communications|December 15, 2022
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trialDarin T Okuda, Daniel Kantor, Mark Jaros, et al.Parkinsonism & Related Disorders|March 1, 2022
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesOlivier Rascol, Lars Tönges, Tina deVries, et al.Nature Reviews. Neurology|October 7, 2009
Unanticipated demyelinating pathology of the CNSDarin T OkudaHandbook of Clinical Neurology|February 11, 2014
Immunosuppressive treatments in multiple sclerosisDarin T OkudaNeuroimaging Clinics of North America|April 11, 2017
Radiologically Isolated Syndrome: MR Imaging Features Suggestive of Multiple Sclerosis Prior to First Symptom OnsetDarin T OkudaContinuum (Minneapolis, Minn.)|June 5, 2016
Incidental Lesions Suggesting Multiple SclerosisDarin T OkudaJournal of Central Nervous System Disease|January 7, 2025
Transforming grayscale MRI images to color utilizing generative artificial intelligence to better understand multiple sclerosisDarin T Okuda, Christine Lebrun-FrénayNeurologic Clinics|November 22, 2017
Multiple Sclerosis in the Contemporary Age: Understanding the Millennial Patient with Multiple Sclerosis to Create Next-Generation CareMadison R Hansen, Darin T OkudaAnnals of the New York Academy of Sciences|June 8, 2018
Precision medicine for multiple sclerosis promotes preventative medicineMadison R Hansen, Darin T OkudaPageof 18